首页 | 本学科首页   官方微博 | 高级检索  
     


Allele frequency distribution of CYP2C9*2 and CYP2C9*3 polymorphisms in six Mexican populations
Authors:Osvaldo D. Castelá  n-Martí  nez,Carlos Hoyo-Vadillo,Emmanuel Sandoval-Garcí  a,Lucila Sandoval-Ramí  rez,Miriam Gonzá  lez-Ibarra,Gloria Solano-Solano,Rita A. Gó  mez-Dí  az,Esteban J. Parra,Miguel Cruz,Adá  n Valladares-Salgado
Affiliation:1. Unidad de Investigación Médica en Bioquímica Centro Médico Nacional, “Siglo XXI” IMSS, Mexico;2. Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados, IPN, Mexico;3. Centro de Investigación Biomédica de Occidente, CMNO, IMSS, Mexico;4. Instituto de Ciencias de la Salud, Universidad Autónoma del Estado de Hidalgo, Mexico;5. Unidad de Investigación Médica en Epidemiología Clínica, Centro Médico Nacional, “Siglo XXI” IMSS, Mexico;6. Department of Anthropology, University of Toronto at Mississauga, ON, Canada
Abstract:
Allele frequency differences of functional CYP2C9 polymorphisms are responsible for some of the variation in drug response observed in human populations. The most relevant CYP2C9 functional variants are CYP2C9*2 (rs1799853) and CYP2C9*3 (rs1057910). These polymorphisms show variation in allele frequencies among different population groups. The present study aimed to analyze these polymorphisms in 947 Mexican-Mestizo from Mexico City and 483 individuals from five indigenous Mexican populations: Nahua, Teenek, Tarahumara, Purepecha and Huichol. The CYP2C9*2 allele frequencies in the Mestizo, Nahua and Teenek populations were 0.051, 0.007 and 0.005, respectively. As for CYP2C9*3, the allelic frequencies in the Mestizo, Nahua and Teenek populations were 0.04, 0.005 and 0.005, respectively. The CYP2C9*2 and CYP2C9*3 alleles were not observed in the Tarahumara, Purepecha and Huichol populations. These findings are in agreement with previous studies reporting very low allele frequencies for these polymorphisms in American Indigenous populations.
Keywords:CEPH-HGDP, Centre d'Etude du Polymorphisme Humain-Human Genome Diversity Project   CYP, cytochrome P-450   CYP2C9, cytochrome P-450 CYP2C9 gene   CYP2C9*1, allele 1 of the CYP2C9 gene   CYP2C9*2, allele 2 of the CYP2C9 gene   CYP2C9*3, allele 3 of the CYP2C9 gene   DNA, deoxyribonucleic acid   IMSS, Mexican Institute of Social Security   LA, Los Angeles, CA, USA.   PCR, polymerase chain reaction   VKORC1, vitamin K epoxidase gene   SNP, single nucleotide polymorphism
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号